Study
L-arginine and Vitamin C Improve Daily Life for Seniors with COPD
Taking L-arginine with vitamin C helps seniors with COPD breathe easier and stay active.
Summary
In plain language
Recent research shows that supplementing with L-arginine and vitamin C can help seniors with Chronic Obstructive Pulmonary Disease (COPD) improve their breathing and daily activities. In a study, participants taking these supplements twice daily experienced less difficulty breathing and were able to perform daily tasks more easily than those who took a placebo. This improvement in their quality of life is significant, especially considering the challenges COPD brings. For seniors living with COPD, adding these supplements to their routine might offer a new way to enhance their daily living and comfort.
Details
Use the full description to understand the study design, methods, and the limits of the findings.
This study was conducted over four weeks and involved 150 patients with stable COPD. Participants were given either L-arginine and vitamin C supplements or a placebo. Researchers measured changes in breathing difficulties and daily activity performance using standardized questionnaires.
The study found that those taking supplements showed significant improvements in breathing and daily activities compared to the placebo group.
Improvements were measured through questionnaires assessing quality of life and breathing ease.
While promising, further research is needed to understand long-term effects and confirm findings.
Seniors with COPD might consider discussing with their healthcare providers whether L-arginine and vitamin C supplements could be beneficial for them.
Full Study
Open the original publication for the complete methods, outcomes, and source material.
L-arginine and Vitamin C Improve Daily Life for Seniors with COPD
Published October 2026
Opens at the publisher · external site · may require institutional access
Research Quality Score
Scored October 22, 2026 using rubric mq-1.8_2026-07-06.
Assessment
The study scored well in study design due to its randomized, placebo-controlled nature. Bias control was limited by single blinding. Statistical integrity was strong with pre-specified endpoints and appropriate analyses. Transparency was moderate due to partial registration details. Conflicts were not fully transparent, affecting the score. The study was relevant to the target population, but journal quality could not be assessed.
Category Breakdown
| Category | Score | Rating |
|---|---|---|
| Study design | 10.0/10 | |
| Bias control | 6.7/10 | |
| Statistical methods | 10.0/10 | |
| Reporting completeness | 5.0/10 | |
| Conflicts & funding | 5.0/10 | |
| Replication | 0.0/10 | |
| Relevance to chosen population | 10.0/10 | |
| Journal Reliability | 5.0/10 |
Additional Notes
The study investigates the effects of L-arginine and vitamin C supplementation on quality of life and daily activities in COPD patients. It found significant improvements in dyspnea and daily life activities with L-arginine compared to placebo.
Assessed on the study's full text across 8 quality dimensions; conflict-of-interest disclosures were reviewed.
Conditions This Research Covers
These condition pages help connect the paper back to the real-world health concerns it addresses.
Treatments Evaluated in This Research
Review the interventions studied here and compare them against the broader treatment library.
Take the next step
Build a personalized plan using research-backed studies, conditions, and treatments.